First available biosimilar monoclonal antibodies
The review deals with the issues related to the special aspects of the development of the first available similar biopharmaceuticals/biological analogues («biosimilars») based on monoclonal antibodies. In June 2013 the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines A...
Saved in:
| Main Authors: | Zh. I. Avdeeva, A. A. Soldatov, N. A. Alpatova, V. P. Bondarev, Yu. V. Olefir, V. A. Merkulov, V. D. Mosyagin, N. V. Medunitsyn |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Ministry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»
2018-02-01
|
| Series: | Биопрепараты: Профилактика, диагностика, лечение |
| Subjects: | |
| Online Access: | https://www.biopreparations.ru/jour/article/view/67 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Modern biological/biotechnological medicinal products. Topical issues and prospects for development
by: Yu. V. Olefir, et al.
Published: (2018-02-01) -
Quality standards for immunobiological medicinal products - new texts in the State Pharmacopoeia of the Russian Federation
by: A. A. Movsesyants, et al.
Published: (2018-02-01) -
Modern approaches to herbal preparations efficacy and safety assessment in Russia and abroad
by: E. I. Sakanyan, et al.
Published: (2018-02-01) -
Guidelines of research biosimilar drugs
by: R. . Ivanov, et al.
Published: (2014-04-01) -
Фармакодинамика и фармакокинетика нанонейрофармакологических препаратов
Published: (2012-03-01)